June 14, 2018

Philips-commissioned Future Health Index outlines journey to value-based healthcare

Amsterdam, the NetherlandsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today released the first chapter of the 2018 Future Health Index (FHI), a research-based platform designed to help determine the readiness of countries to address global health challenges and build efficient and effective health systems. The FHI focuses on the crucial role that technologies for connected care and digital tools can play in delivering more integrated and sustainable healthcare. 


This year’s FHI analyzes the primary research and third party data from across 16 countries, representing about half of the world’s population. The 2018 FHI introduces the Value Measure, a new indicator of the value delivered by healthcare systems of developed and developing markets. Combining criteria associated with value-based healthcare and access to care, the Value Measure provides a benchmark against which a system’s progress towards efficient and effective healthcare can be evaluated. The report also includes the input from global healthcare experts and provides actionable insights for countries to improve the value that their health systems deliver. 

A new value indicator

In line with the FHI’s historical focus and findings, the Value Measure is based on three key criteria:


  • Access i.e. how universal and affordable is access to healthcare? 
  • Satisfaction i.e. to what extent do the general population and practitioners in each market see their healthcare system as trustworthy and effective?
  • Efficiency i.e. does the system produce outcomes at an optimum cost?


This methodology builds on the fast-growing consensus that the value-based healthcare model is the best approach to address the challenges posed by a combination of growing and aging populations with the rise of chronic diseases and healthcare costs.

Devising a meaningful Value Measure, including access to care next to patient experience and efficiency, is an important step in helping countries to measure their readiness to address healthcare challenges.

Jan Kimpen

Chief Medical Officer for Philips

“Global experts agree on the need to move away from a volume-based measure of healthcare to a value-based one,” said Jan Kimpen, Chief Medical Officer for Philips. “Devising a meaningful Value Measure, including access to care next to patient experience and efficiency, is an important step in helping countries to measure their readiness to address healthcare challenges.”

The role of technology

One of the most important findings from the 2018 FHI is that countries with a high Value Measure tend to exhibit high levels of connected care technology adoption. This indicates that integrating connected care technology into health systems can accelerate countries along the path to value-based healthcare. Health systems that provide universal access to care and deliver effective outcomes, as well as high levels of healthcare professional and general population satisfaction – such as those in Singapore, Sweden and the Netherlands – tend to be those with comparatively high levels of support from advanced data collection and analytics, and that have integrated connected technology into care delivery models.


However, examining the overall Value Measure results across the 16 countries studied indicates that while there is a correlation between a country’s wealth, development levels and ability to deliver value-based healthcare, no one market is a consistent performer across all criteria. Varying pockets of excellence and system shortfalls mean different countries may approach this journey in any number of ways. However, while methods are important, connected care technology is foundational to value-based healthcare. 


Therefore, the next two chapters of the 2018 FHI will take a closer look at two digital enablers, which have the potential to significantly drive change through connected care technologies:


  • Data collection and analytics i.e. the ability to share and collect patient centric data and analyze it on a large scale 
  • Care delivery i.e. technology developments which are bringing innovative ways to deliver better care


To download the first chapter of the 2018 FHI report in its entirety, please visit For additional Future Health Index related content, please visit

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2017 sales of EUR 17.8 billion and employs approximately 74,000 employees with sales and services in more than 100 countries. News about Philips can be found at

Click here to read moreClick here to read less



Elena Calamo Specchia

Elena Calamo Specchia

Philips Global Press Office

Tel: +31 6 25004735

Media assets

2018 Future Health Index

Press releases

Get our press releases by e-mail

Share on social media

  • Link copied

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.